Skip to main content
. 2017 Aug 8;2017:9643139. doi: 10.1155/2017/9643139

Table 4.

Analysis of genotype and acetylation status in BC patients.

Genotype Acetylation status n (%)
NAT2
4/4 Fast 8 (8.8)
4/5 Fast 11 (12.1)
4/6 Intermediate 17 (18.7)
4/7 Intermediate 1 (1.0)
5/5 Slow 16 (17.6)
5/6 Slow 26 (28.6)
5/7 Slow 3 (3.3)
6/6 Slow 4 (4.4)
6/7 Slow 5 (5.5)